Delivery Order SPE2DB20D2104-SPE2DB23FV45Z
Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order worth $13,703.68 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide NURTEC ODT 75 MG TABLET 8S. The delivery order has a firm fixed price and an ultimate completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range...
- This is a $5,689.19 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of May 31, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a firm fixed price of $5,513.79 and a ceiling value of $5,513.79. The ultimate completion date is August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This is a $52,197.41 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG TABLET 8S. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order has a firm fixed price and does not have a...
- This is a $39,903.89 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565711516 NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,288.36, is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a $7,675.72 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for NURTEC ODT 75 MG TABLET 8S and has a period of performance through July 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,802.97, is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription drug product. The contract has an ultimate completion date of January 17, 2024 and is a firm fixed-price type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,786.07, is for the supply of NURTEC ODT 75 MG TABLET 8S, a medical product. The contract is a firm fixed-price, Delivery Order type, with an ultimate completion date of April 11, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the provision of NURTEC ODT 75 MG TABLET 8S. The firm-fixed-price contract has a ceiling value of $18,578.17 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV45ZDelivery Order
This is a $5,969.75 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NURTEC ODT 75 MG TABLET 8S. The contract has an ultimate completion date of September 22, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 2/27/25, 9:58 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/21/23 |